Kuros Biosciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '25 Dec 18, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	1,068	806	128	54	63	66	Upgrade
Market Cap Growth	42.14%	528.00%	138.81%	-14.90%	-4.70%	20.42%	Upgrade
Enterprise Value	1,051	793	114	34	38	54	Upgrade
Last Close Price	27.28	21.35	3.49	1.47	1.93	2.02	Upgrade
PS Ratio	10.34	10.66	3.82	2.99	4.57	16.40	Upgrade
PB Ratio	13.93	13.71	2.26	0.78	0.82	0.78	Upgrade
P/TBV Ratio	30.66	33.12	8.15	2.67	3.01	2.45	Upgrade
P/FCF Ratio	-	393.96	-	-	-	-	Upgrade
P/OCF Ratio	1302.61	256.57	-	-	-	-	Upgrade
EV/Sales Ratio	10.17	10.50	3.41	1.90	2.77	13.27	Upgrade
EV/EBITDA Ratio	162.08	385.86	-	-	-	-	Upgrade
EV/EBIT Ratio	272.76	7414.24	-	-	-	-	Upgrade
EV/FCF Ratio	-1560.07	387.93	-	-	-	-	Upgrade
Debt / Equity Ratio	0.02	0.03	0.04	0.03	0.03	0.03	Upgrade
Debt / EBITDA Ratio	0.28	0.66	-	-	-	-	Upgrade
Debt / FCF Ratio	-	0.88	-	-	-	-	Upgrade
Asset Turnover	1.10	0.97	0.44	0.21	0.15	0.04	Upgrade
Inventory Turnover	1.14	1.18	1.27	1.47	2.33	1.96	Upgrade
Quick Ratio	1.68	1.64	2.22	2.20	2.72	7.69	Upgrade
Current Ratio	2.25	2.14	2.77	2.49	2.91	8.76	Upgrade
Return on Equity (ROE)	-8.62%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%	Upgrade
Return on Assets (ROA)	2.57%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%	Upgrade
Return on Capital (ROIC)	3.43%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%	Upgrade
Return on Capital Employed (ROCE)	4.60%	0.20%	-8.20%	-14.00%	-11.00%	-13.00%	Upgrade
Earnings Yield	-0.57%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%	Upgrade
FCF Yield	-0.06%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%	Upgrade
Buyback Yield / Dilution	-36.07%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.